Viewing Study NCT00295035


Ignite Creation Date: 2025-12-24 @ 10:04 PM
Ignite Modification Date: 2026-01-24 @ 5:38 AM
Study NCT ID: NCT00295035
Status: UNKNOWN
Last Update Posted: 2006-02-22
First Post: 2006-02-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer
Sponsor: Tel-Aviv Sourasky Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module